Suppr超能文献

人半乳糖凝集素-4 N端碳水化合物识别结构域与甘油、乳糖、3'-磺基乳糖和2'-岩藻糖基乳糖复合物的结构表征

Structural characterisation of human galectin-4 N-terminal carbohydrate recognition domain in complex with glycerol, lactose, 3'-sulfo-lactose, and 2'-fucosyllactose.

作者信息

Bum-Erdene Khuchtumur, Leffler Hakon, Nilsson Ulf J, Blanchard Helen

机构信息

Institute for Glycomics, Griffith University, Gold Coast Campus, Queensland 4222, Australia.

Section MIG, Department of Laboratory Medicine, Lund University, BMC-C1228b, Klinikgatan 28, SE-22184 Lund, Sweden.

出版信息

Sci Rep. 2016 Feb 1;6:20289. doi: 10.1038/srep20289.

Abstract

Galectin-4 is a tandem-repeat galectin with two distinct carbohydrate recognition domains (CRD). Galectin-4 is expressed mainly in the alimentary tract and is proposed to function as a lipid raft and adherens junction stabilizer by its glycan cross-linking capacity. Galectin-4 plays divergent roles in cancer and inflammatory conditions, either promoting or inhibiting each disease progression, depending on the specific pathological condition. The study of galectin-4's ligand-binding profile may help decipher its roles under specific conditions. Here we present the X-ray structures of human galectin-4 N-terminal CRD (galectin-4N) bound to different saccharide ligands. Galectin-4's overall fold and its core interactions to lactose are similar to other galectin CRDs. Galectin-4N recognises the sulfate cap of 3'-sulfated glycans by a weak interaction through Arg45 and two water-mediated hydrogen bonds via Trp84 and Asn49. When galectin-4N interacts with the H-antigen mimic, 2'-fucosyllactose, an interaction is formed between the ring oxygen of fucose and Arg45. The extended binding site of galectin-4N may not be well suited to the A/B-antigen determinants, α-GalNAc/α-Gal, specifically due to clashes with residue Phe47. Overall, galectin-4N favours sulfated glycans whilst galectin-4C prefers blood group determinants. However, the two CRDs of galectin-4 can, to a less extent, recognise each other's ligands.

摘要

半乳糖凝集素-4是一种具有两个不同碳水化合物识别结构域(CRD)的串联重复半乳糖凝集素。半乳糖凝集素-4主要在消化道表达,因其聚糖交联能力而被认为具有脂质筏和黏附连接稳定剂的功能。半乳糖凝集素-4在癌症和炎症性疾病中发挥着不同的作用,根据具体病理状况,它既可以促进也可以抑制每种疾病的进展。对半乳糖凝集素-4配体结合谱的研究可能有助于解读其在特定条件下的作用。在此,我们展示了与不同糖类配体结合的人半乳糖凝集素-4 N端CRD(半乳糖凝集素-4N)的X射线晶体结构。半乳糖凝集素-4的整体折叠及其与乳糖的核心相互作用与其他半乳糖凝集素CRD相似。半乳糖凝集素-4N通过精氨酸45的弱相互作用以及经由色氨酸84和天冬酰胺49的两个水介导氢键识别3'-硫酸化聚糖的硫酸基团。当半乳糖凝集素-4N与H抗原模拟物2'-岩藻糖基乳糖相互作用时,岩藻糖的环氧与精氨酸45之间形成相互作用。半乳糖凝集素-4N的扩展结合位点可能不太适合A/B抗原决定簇α-氨基半乳糖/α-半乳糖,特别是由于与苯丙氨酸47的冲突。总体而言,半乳糖凝集素-4N偏爱硫酸化聚糖,而半乳糖凝集素-4C更喜欢血型决定簇。然而半乳糖凝集素-4的两个CRD在较小程度上可以识别彼此的配体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75da/4734333/cbfb7912d335/srep20289-f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验